Chlorpyrifos

Hayes' Handbook of Pesticide Toxicology

Volumn , Issue , 2010, Pages 1505-1526

  Testai, Emanuela ^a   Buratti, Franca M ^a   Di Consiglio, Emma ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866361686     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374367-1.00070-7     Document Type: Chapter

References (256)

1. (14)C]chlorpyrifos in pregnant rats. Arch. Toxicol. 2002, 76:452-459.
2. Adgate J.L., Barr D.B., Clayton C.A., Eberly L.E., Freeman N.C.G., Lioy P.J., Needham L.L., Pellizzari E.D., Quackenboss J.J., Roy A., Sexton K. Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ. Health Perspect. 2001, 109(6):583-589.
3. Aiuto L.A., Pavlakis S.G., Boxer R.A. Life-threatening organophosphate-induced delayed polyneuropathy in a child after accidental chlorpyrifos ingestion. J. Pediatr. 1993, 122(4):658-660.
4. Akhtar N., Srivastava M.K., Raizada R.B. Transplacental disposition and teratogenic effects of chlorpyrifos in rats. J. Toxicol. Sci. 2006, 31(5):521-527.
5. Aldridge W.N. The esterases: perspectives and problems. Chem-Biol. Interact. 1993, 87:5-13.
6. Aldridge J.E., Levin E.D., Seidler F.J., Slotkin T.A. Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ. Health Perspect. 2005, 113(5):527-531.
7. Aldridge J.E., Meyer A., Seidler F.J., Slotkin T.A. Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ. Health Perspect. 2005, 113(8):1027-1031.
8. Aldridge J.E., Meyer A., Seidler F.J., Slotkin T.A. Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions. Toxicol. Appl. Pharmacol. 2005, 203:134-144.
9. Aldridge J.E., Seidler F.J., Meyer A., Thillai I., Slotkin T.A. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ. Health Perspect. 2003, 111:1736-1743.
10. Alexander B.H., Burns C.J., Bartels M.J., Acquavella J.F., Mandel J.F., Gustin C., Baker B.A. Chlorpyrifos exposure in farm families: Results from the farm family exposure study. J. Expos. Sci. Environ. Epidemiol. 2006, 16:447-456.
11. Amer S.M., Aly F.A. Cytogenetic effects of pesticides. IV. Cytogenetic effects of the insecticides Gardona and Dursban. Mutat. Res. 1992, 279:165-170.
12. I. Documentation of the Threshold Limit Values and Biological Exposure Indices 1986, American Conference of Governmental Industrial Hygienists, Cincinnati, OH, pp. 5-48. 5th ed.
13. Anon (1996). Neurotoxicity study of chlorpyrifos technical to hen. Report 1539/JRF/TOX/96, dated 10 February 1996. Department of Toxicology, Jai, Research Foundation, India.
14. Bagchi D., Bagchi M., Hassoun E.A., Stohs S.J. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology 1995, 104(1-3):129-140.
15. Barone S., Das K.P., Lassiter T.L., White P.C. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 2000, 21:15-36.
16. Barr D.B., Barr J.R., Maggio V.L., Whitehead R.D., Sadowski M.A., Whyatt R.M., Needham L.L. A multi-analyte method for the quantification of contemporary pesticides in human serum and plasma using high-resolution mass spectrometry. J. Chromatogr. B 2002, 778:99-111.
17. Beach J.R., Spurgeon A., Stephens R.E.A. Abnormalities on neurological examination amond sheep farmers exposed to organophosphorous pesticides. Occup. Environ. Med. 1996, 53:520-525.
18. Bebe F.N., Panemangalore M. Exposure to low doses of endosulfan and chlorpyrifos modifies endogenous antioxidants in tissues of rats. J. Environ. Sci. Health B 2003, 38:349-363.
19. Berkowitz G.S., Wetmure J.G., Birman-Deych E., Obel J., Lapinsky R.H., Godbold J.H., Holzman I.R., Wolff M.S. In utero pesticide exposure, maternal paraoxonase activity, and head circunference. Environ. Health Perspect. 2004, 112(3):388-391.
20. Berteau P.E., Deen W.A. A comparison of oral and inhalation toxicities of four insecticides to mice and rats. Bull. Environ. Contam. Toxicol. 1978, 19:113-120.
21. Bicker W., Lammerhofer M., Genser D., Kiss H., Lindner W. A case study of acute human chlorpyrifos poisoning: Novel aspects on metabolism and toxicokinetics derived from liquid Noromatography-tandem mass spectrometry analysis of urine samples. Toxicol. Lett. 2005, 159:235-251.
22. Bicker W., Lammerhofer M., Lindner W. Determination of chlorpyrifos metabolites in human urine by reversed phase/weak anion exchange liquid chromatography-electrospray ionisation-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2005, 822:160-169.
23. Bigbee J.W., Sharma V.K., Gupta J.J., Dupree J.L. Morphogenic role of acetylcholinesterase in axonal outgrowth during neuroal development. Environ. Health Perspect. 1999, 107(Suppl):181-187.
24. Bignami, G., Rosic, N., Michalek, H., Milosevic, M., and Gatti, G. L. (1975). Behavioral toxicity of anticholinesterase agents: Methodological, neurochemical, and neuropsychological aspects. In "Behavioral Toxicology" (Plenum Press, ed.), pp. 155-215. New York.
25. Blondell, J. (2000). Chlorpyrifos incident review update, Review of MRID nos. 43480001, 44039901, 44186301, 44245801, 1997 Epidemiology Panel Report and 1995 critique of EPA's review of neuropathy allegations.
26. Bouchard M., Carrier G., Brunet R.C., Bonvalot Y., Gosselin N.H. Determination of biological reference values for chlorpyrifos metabolites in human urine using a toxicokinetic approach. J. Occup. Environ. Hyg. 2005, 2(3):155-168.
27. Brenner F.E., Bond G.G., McLaren E.A., Green S., Cook R.R. Morbidity among employees engaged in the manufacture or formulation of chlorpyrifos. Br. J. Ind. Med. 1989, 46:133-137.
28. Breslin, W. J., Liberacki, A. B., Dittenber, D. A., Brzak, K. A., and Quast, J. F. (1991). Chlorpyrifos: two-generation dietary reproduction study in Sprague-Dawley rats. Toxicology Research Laboratory, Dow Chemical Co. No. K-044793-088. Midland, MI, Submitted to WHO by Dow AgroSciences, Indianapolis, Indiana, USA.
29. Breslin W.J., Liberacki A.B., Dittenber D.A., Quast J.F. Evaluation of the developmental and reproductive toxicity of chlorpyrifos in the rat. Fundam. Appl. Toxicol. 1996, 29(1):119-130.
30. Brimijoin S., Koenigsberger C. Cholinesterase in neural development: new findings and toxicologic implications. Environ. Health Perspect. 1999, 107(Suppl 1):59-64.
31. Buratti F.M., Leoni C., Testai E. Foetal and adult human CYP3A isoform in the bioactivation of organophosphorothionate insecticides. Toxicol. Lett. 2006, 167:245-255.
32. Buratti F.M., Testai E. Malathion detoxification by human hepatic carboxylesterases and its inhibition by isomalathion and other pesticides. J. Biochem. Mol. Toxicol. 2005, 19(6):406-414.
33. Buratti F.M., Volpe M.T., Fabrizi L., Meneguz A., Vittozzi L., Testai E. Kinetic parameters of OPT pesticide desulfuration by c-DNA expressed human CYPs. Environ. Toxicol. Pharmacol. 2002, 11(3-4):181-190.
34. Buratti F.M., Volpe M.T., Meneguz A., Vittozzi L., Testai E. CYP-specific bioactivation of four organophosphorothionate pesticides by human liver microsomes. Toxicol. Appl. Pharmacol. 2003, 186:143-154.
35. Bushnell P.J., Kelly K.L., Ward T.R. Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance. J. Pharmacol. Exp. Ther. 1994, 270(1):15-25.
36. Bushnell P.J., Moser V.C., Samsam T.E. Comparing cognitive and screening tests for neurotoxicity. Effects of acute chlorpyrifos on visual signal detection and a neurobehavioral test battery in rats. Neurotoxicol. Teratol. 2001, 23(1):33-44.
37. Bushnell P.J., Pope C.N., Padilla S. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase. J. Pharmacol. Exp. Ther. 1993, 266(2):1007-1017.
38. Byrne S.L., Schurdut B.A., Saunders D.G. Potential chlorpyrifos exposure to residents following standard crack and crevice treatment. Environ. Health Perspect. 1998, 106:725-731.
39. Capodicasa E., Scapellato M.L., Moretto A., Caroldi S., Lotti M. Chlorpyrifos-induced delayed polyneuropathy. Arch. Toxicol. 1991, 65(2):150-155.
40. Carr R.L., Chambers H.W., Guarisco J.A., Richardson J.R., Tang J., Chambers J.E. Effects of repeated oral postnatal exposure to chlorpyrifos on open-field behavior in juvenile rats. Toxicol. Sci. 2001, 59(2):260-267.
41. Casida J.E., Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 2004, 17(8):983-998.
42. CFSAN (2001). Pesticides and chemical contaminants: Total Diet Study. FDA. Program areas.
43. Chambers J.E., Carr R.L. Inhibition patterns of brain acetylcholinesterase and hepatic and plasma aliesterases following exposures to three phosphorothionate insecticides and their oxons in rats. Fundam. Appl. Toxicol. 1993, 21:111-119.
44. Chambers J.E., Chambers H.W. Oxidative desulfuration of chlorpyrifos, chlorpyrifos-methyl, and leptophos by rat brain and liver. J. Biochem. Toxicol. 1989, 4(3):201-203.
45. Chanda S.M., Harp P., Liu J., Pope C.N. Comparative developmental and maternal neurotoxicity following acute gestational exposure to chlorpyrifos in rats. J. Toxicol. Environ. Health 1995, 44(2):189-202.
46. Chanda S.M., Mortensen S.R., Moser V.C., Padilla S. Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: An in vitro and in vivo comparison. Fundam. Appl. Toxicol. 1997, 38:148-157.
47. Chanda S.M., Pope C.N. Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats. Pharmacol. Biochem. Behav. 1996, 53(4):771-776.
48. Choi K., Hodgson E., Rose R.L. Inhibition of trans-permethrin hydrolysis in human liver fractions by chloropyrifos oxon and carbaryl. Drug Metabol. Drug Intereact. 2004, 20:233-246.
49. Choi K., Joo H., Rose R.L., Hodgson E. Metabolism of chlorpyrifos and chlorpyrifos oxon by human hepatocytes. J. Biochem. Mol. Toxicol. 2006, 20:279-291.
50. Choi K., Rose R.L., Hodgson E. In vitro human metabolism of permethrin: the role of human alcohol and aldehyde dehydrogenases. Pest. Biochem. Physiol. 2003, 73:117-128.
51. Clegg D.J., van Gemert M. Determination of the reference dose for chlorpyrifos: proceedings of an expert panel. J. Toxicol. Environ. Health Part B Crit. Rev. 1999, 2(3):211-255.
52. Cleveland C.B., Oliver G.R., Chen B., Mattsson J. Risk assessment under FQPA: case study with chlorpyrifos. Neurotoxicology 2001, 22(5):699-706.
53. Cochran R.C., Kishiyama J., Aldous C., Carr Jr W.C., Pfeifer K.F. Chlorpyrifos: hazard assessment based on a review of the effects of short-term and long-term exposure in animals and humans. Food Chem. Toxicol. 2009, 33:165-172.
54. Cometa M.F., Buratti F.M., Fortuna S., Lorenzini P., Volpe M.T., Parisi L., Testai E., Meneguz A. Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice. Toxicology 2007, 234(1-2):90-102.
55. Cook T.J., Shenoy S.S. Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat. Toxicology 2003, 184:125-133.
56. Corley R.A., Calhoun L.L., Dittenber D.A., Lomax L.G., Landry T.D. Chlorpyrifos: A 13-week nose-only vapor inhalation study in Fischer 344 rats. Fundam. Appl. Toxicol. 2009, 13:616-618.
57. Costa L.G., Current issues in organophosphate toxicology. Clinica Chimica Acta 2006, 366:1-13.
58. Costa L.G., Cole T.B., Vitalone A., Furlong C.E. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clinica Chimica Acta 2005, 352:37-47.
59. Costa L.G., Vitalone A., Cole T.B., Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 2005, 69:541-550.
60. Costa L.G., Richter R.J., Li W.-F., Cole T.B., Guizzetti M., Furlong C.E. Paraoxonase (PON1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 2003, 8(1):1-12.
61. Coulston, F., Goldberg, L., and Griffin, T. (1972). Safety evaluation of Dow co. 179 in humans. Inst. Exp. Pathol. Toxicol. Unpublished report. Albany Medical College.
62. Curwin B.D., Hein M.J., Sanderson W.T., Striley C., Heederik D., Kromhout H., Reynolds S.J., Alavanja M.C. Pesticide dose estimates for children of Iowa farmers and non-farmers. Environ. Res. 2007, 105:307-315.
63. Curwin B.D., Hein M.J., Sanderson W.T., Striley C., Heederik D., Kromhout H., Reynolds S.J., Alavanja M.C. Urinary pesticide concentrations among children, mothers and fathers living in farm and non-farm households in Iowa. Ann. Occup. Hyg. 2007, 51:53-65.
64. da Silva V.I.J., Totino L.T., Michelon A., Sanchez Ferreira C.A., Joaquim de Freitas D.R. Effect of acaricides on the activity of a Boophilus microplus glutathione S-transferase. Vet. Parasitol. 2004, 119:237-245.
65. Dam K., Seidler F.J., Slotkin T.A. Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Brain Res. Dev. Brain Res. 2000, 121:179-187.
66. Deacon M.M., Murray J.S., Pilny M.K., Rao K.S., Dittenber D.A., Hanley T.R., John J.A. Embryotoxicity and fetotoxicity of orally administered chlorpyrifos in mice. Toxicol. Appl. Pharmacol. 1980, 54:31-40.
67. Di Consiglio E., Meneguz A., Testai E. Organophosphorothionate pesticides inhibit the bioactivation of imipramine by human hepatic cytochrome P450s. Toxicol. Appl. Pharmacol. 2005, 205:237-246.
68. Diepgen T.L., Geldmacher-von Mallinckrodt M. Interethnic differences in the detoxification of organophosphates: the human serum paraoxonase polymorphism. Arch. Toxicol. Suppl. 1986, 9:154-158.
69. Acute Inhalation Toxicity Study in Rats Exposed to Pyrenone Dursban Aqueous Base 1983, Dow, Cosmopolitan Safety Evaluation, Inc., Lafayette, NJ.
70. Dow Chemical Co. (1986). Summary of Acute Dermal Toxicity Study on Chlorpyrifos in Fischer 344 rats. 5-46. Indianapolis, IN.
71. Dyer S.M., Cattani M., Pisaniello D.L., Williams F.M., Edwards J.W. Peripheral cholinesterase inhibition by occupational chlorpyrifos exposure in Australian termiticide applicators. Toxicology 2001, 169(3):177-185.
72. Eaton D.L., Daroff R.B., Autrup H., Bridges J., Buffler P., Costa L.G., Coyle J., McKhann G., Mobley W.C., Nadel L., Neubert D., Schulte-Hermann R., Spencer P.S. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit. Rev. Toxicol. 2008, 38(Suppl 2):1-125.
73. Ecobichon D.J. Toxic effects of pesticides. Casarett & Doull's Toxicology: The Basic Science of Poisons 1996, 643-689. McGraw-Hill, New York, NY. C.D. Klaassen, M.O. Amdur, J. Doull (Eds.).
74. Eddleston M., Buckley N.A., Eyer P., Dawson A.H. Management of acute organophosphorus pesticide poisoning. Lancet 2007, 371:597-607.
75. Eddleston M., Eyer P., Worek F., Mohamed F., Senarathna L., von Meyer L., Juszczak E., Hittarage A., Azhar S., Dissanayake W., Rezvi Sheriff M.H., Szinicz L., Dawson A.H., Buckley N.A. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005, 366:1452-1459.
76. Eddleston M., Phillips M.R. Self-poisoning with pesticides. Brit. Med. J. 2004, 328:42-44.
77. Eskenazi B., Harley K., Bradman A., Weltzien E., Jewell N.P., Barr D.B., Furlong C.E., Holland N.T. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in a agricultural population. Environ. Health Perspect. 2004, 112:1116-1124.
78. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., Morga N., Jewell N.P. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ. Health Perspect. 2007, 115(5):792-798.
79. EU (2005). Review report for the active substance chlorpyrifos. European Commission Health & Consumer Protection Directorate-general.
80. Fagerholm U., Johansson M., Lennemas H. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 1996, 13:1336-1342.
81. Farag A.T., El Okazy A.M., El Aswed A.F. Developmental toxicity study of chlorpyrifos in rats. Reprod. Toxicol. 2003, 17(2):203-208.
82. Fenske R.A., Kedan G., Lu C., Fisker-Andersen J.A., Curl C.L. Assessment of organophosphorus pesticide exposure in the diets of preschool children in Washington State. J. Expos. Anal. Environ. Epidemiol. 2002, 12:21-28.
83. Fenske R.A., Lu C., Barr D., Needham L. Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. Environ. Health Perspect. 2002, 110:549-553.
84. Fenske R.A., Kissel J.C., Lu C., Kalman D.A., Simcox N.J., Allen E.H., Keifer M.C. Biologically based pesticide dose estimates for children in an agricultural community. Environ. Health Perspect. 2000, 108:515-520.
85. Forsyth C.S., Chambers J.E. Activation and degradation of the phosphorothionate insecticides parathion and EPN by rat brain. Biochem. Pharmacol. 1989, 38:1597-1603.
86. FQPA (1996). Food Quality Protection Act, Public Law No. 104-170.
87. Fujioka K., Casida J.E. Glutathione S-transferase conjugation of organophosphorus pesticides yields S-phospho-, S-aryl-, and S-alkylglutathione derivatives. Chem. Res. Toxicol. 2007, 20(8):1211-1217.
88. Furlong C.E. Genetic variability in the cytochrome P450-paraoxonase (PON1) pathways for the detoxication of organophosphorus compounds. J. Biochem. Mol. Toxicol. 2007, 21:197-205.
89. Furlong C.E., Li W.-F., Costa L.G., Richter R.J., Shih D.M., Lusis A.J. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1. Neurotoxicology 1998, 19(4-5):645-650.
90. Gallo M.A. Organic Phosphorus Pesticides 1991, Academic Press, San Diego.
91. Garabrant, D. H., Aylward, L. L., Berent, S., Chen, Q., Timchalk, C., Burns, C. J., Hays, S. M., and Albers, J. W. (2008). Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy. J. Expo. Sci. Environ. Epidemiol. In press,.
92. Geer L.A., Cardello N., Dellarco M.J., Leighton T.J., Zendzian R.P., Roberts J.D., Buckley T.J. Comparative analysis of passive dosimetry and biomonitoring for assessing chlorpyrifos exposure in pesticide workers. Ann. Occup. Hyg. 2004, 48:683-695.
93. Gollapudi B.B., Mendrala A.L., Linscombe V.A. Evaluation of the genetic toxicity of the organophosphate insecticide chlorpyrifos. Mutat. Res. 1995, 342:25-36.
94. Griffin P., Mason H., Heywood K., Cocker J. Oral and dermal absorption of chlorpyrifos: A human volunteer study. J. Occup. Environ. Med. 1999, 56:10-13.
95. Griffin P., Payne M., Mason H., Freedlander E., Curran A.D., Cocker J. The in vitro percutaneous penetration of chlorpyrifos. Hum. Exp. Toxicol. 2000, 19:104-107.
96. Gur, E., Nyska, A., and Waner, T. (1991). Pyrinex technical oncogenicity study in the mouse. Life Science Research Israel Ltd. Report: R-4985, Project MAK/106/PYR, February, 1991. Final LSRI report undated. Makteshim. Chemical.
97. Gurunathan S., Robson M., Freeman N., Buckley B., Roy A., Meyer R., Bukowski J., Lioy P.J. Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ. Health Perspect. 1998, 106:9-16.
98. Halpert J.A., Hammond D., Neal R.A. Inactivation of purified rat liver cytochrome P-450 during the metabolism of parathion (Diethyl-p-nitrophenyl-phosphorothionate). J. Biol. Chem. 1980, 255:1080-1089.
99. Hirom P.C., Millburn P., Smith R.L., Williams R.T. Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions. Biochem. J. 1972, 129:1071-1077.
100. Hoberman, A. M. (1998). Developmental neurotoxicity study of chlorpyrifos administered orally via gavage to Crl:CD.BR VAF/Plus presumed pregnant rats. Argus Research laboratories. No. K-044793109. Horsham, PA, USA, Submitted to WHO by Dow AgroSciences, Indianapolis, Indiana, USA.
101. Hodgson E., Rose R.L. Organophosphorus chemicals: potent inhibitors of the human metabolism of steroid hormones and xenobiotics. Drug Metab. Rev. 2006, 38:149-162.
102. Hodgson E., Rose R.L. Human metabolic interactions of environmental chemicals. J. Biochem. Mol. Toxicol. 2007, 21(4):182-186.
103. Hosokawa M., Endo T., Fujisawa M., Hara S., Iwata N., Sato Y., Satoh T. Interindividual variation in carboxylesterase levels in human liver microsomes. Drug Metab. Disp. 1995, 23(10):1022-1027.
104. Hosokawa M., Maki T., Satoh T. Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch. Biochem. Biophys. 1990, 277:219-227.
105. Huff R.A., Corcoran J.J., Anderson J.K., Abou-Donia M.B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharmacol. Exp. Ther. 1994, 269(1):329-335.
106. Imai T., Taketani M., Shii M., Hosokawa M., Chiba K. Substrate specificity of carboxylesterase isoenzymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab. Disp. 2006, 34(10):1734-1741.
107. Ingelman-Sundberg M. Polymorphism of cytochrome P450 and xenobiotic toxicity. Toxicology 2002, 181-182:447-452.
108. Jamal G.A., Hansen S., Julu P.O.O. Low level exposures to organophosphorus esters may cause neurotoxicity. Toxicology 2002, 181-182:23-33.
109. James, P., Stubbs, A., Parker, C. A., Offer, J. M., and Anderson, A. (1988). The effect of Pyrinex (chlorpyrifos) on reproductive function of two generations in the rat. Huntingdon Research Centre, Ltd. No. MBS 29/881452. Huntingdon, UK, Submitted to WHO by Makteshim Chemical Works, Beer-Sheva, Israel.
110. Joo H., Choi K., Rose R.L., Hodgson E. Inhibition of fipronil and nonane metabolism in human liver microsomes and human cytochrome P450 isoforms by chlorpyrifos. J. Biochem. Mol. Toxicol. 2007, 21:76-80.
111. Kacham R., Karanth S., Baireddy P., Liu J., Pope C. Interactive toxicity of chlorpyrifos and parathion in neonatal rats: role of esterases in exposure sequence-dependent toxicity. Toxicol. Appl. Pharmacol. 2006, 210:142-149.
112. Kaplan J.G., Kessler J., Rosemberg N., Schaumburg H.H. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology 1993, 43:2193-2196.
113. Karanth S., Liu J., Olivier K., Pope C. Interactive toxicity of the organophosphorus insecticide chlorpyrifos and methyl chlorpyrifos in adult rats. Toxicol. Appl. Pharmacol. 2004, 196:183-190.
114. Karanth S., Olivier K., Liu J., Pope C. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxicity. Toxicol. Appl. Pharmacol. 2001, 177:247-255.
115. Karanth S., Pope C. Carboxylesterase and A-esterase activities during maturation and aging: Relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol. Sci. 2000, 58:282-289.
116. Kidd H., James D.R. The Agrochemicals Handbook 1991, Royal Society of Chemistry Information Services, Cambridge, UK, pp. 5-14.
117. Kisciki, J. C., Seip, C. W., and Combs, M. L. (1999). A rising dose toxicology study to determine the no-observable-effect-levels (NOEL) for erythrocyte acetylcholinesterase (AchE) inhibition and cholinergic signs and symptoms of chlorpyrifos at three dose levels. Unpublished report from MDS Harris. MRID No. 44811002.
118. Klaassen C.D. Casarett & Doull's Toxicology: The Basic Science of Poisons 2001, McGraw-Hill, New York, NY.
119. Krieger R.I. Pesticide exposure assessment. Toxicol. Lett. 1995, 82/83:65-72.
120. Kutz F., Cook B.T., Carter-Pokras O.D., Brody D., Murphy R.S. Selected pesticide residues and metabolites in urine from a survey of the US general population. J. Toxicol. Envirom. Health 1992, 37:277-291.
121. Langley R., Sumner D. Pesticide mortality in the United States, 1979-1988. Vet. Human Toxicol. 2002, 44:105.
122. Lanning C.L., Fine R.L., Sachs C.W., Rao U.S., Corcoran J.J., Abou-Donia M.B. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein. J. Toxicol. Env. Health 1996, 47:395-407.
123. Lassiter T.L., Barone S.J., Moser V.C., Padilla S. Gestational exposure to chlorpyrifos: dose response profiles for cholinesterase and carboxylesterase activity. Toxicol. Sci. 1999, 52(1):92-100.
124. Lassiter T.L., Padilla S., Mortensen S.R., Chanda S.M., Moser V.C., Barone S.J. Gestational exposure to chlorpyrifos: apparent protection of the fetus?. Toxicol. Appl. Pharmacol. 1998, 152(1):56-65.
125. Lauder J.M., Schambra U.B. Morphogenetic roles of acetylcholine. Environ. Health Perspect. 1999, 107(Suppl 1):65-69.
126. Layer P.G., Willbold E. Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 1995, 29(3):1-94.
127. Lee W.J., Blair A., Hoppin J.A., Lubin J.H., Rusiecki J.A., Sandler D.P., Dosemeci M., Alavanja M.C.R. Cancer incidence among pesticide applicators exposed to chlorpyrifos in the agricultural health study. J. Natl. Cancer Inst. 2004, 96:1781-1789.
128. Lee W.J., Sandler D.P., Blair A., Samanic C., Cross A.J., Alavanja M.C. Pesticide use and colorectal cancer risk in the Agricultural Health Study. Int. J. Cancer 2007, 121:339-346.
129. Levin E.D., Addy N., Baruah A., Elias A., Christopher N.C., Seidler F.J., Slotkin T.A. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol. Teratol. 2002, 24,6:733-741.
130. Levin E.D., Addy N., Nakajima A., Christopher N.C., Seidler F.J., Slotkin T.A. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Brain Res. Dev. Brain Res. 2001, 130(1):83-89.
131. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 2005, 70:1673-1684.
132. Li W.-F., Furlong C.E., Matthews C., Disteche C.M., Costa L.G. Developmental expression of paraoxonase in mice. Fundam. Appl. Toxicol. 1996, 30(1-part2):55.
133. Li W.F., Furlong C.E., Costa L. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 1995, 76:219-226.
134. Lotti M. Cholinesterase inhibiton: Complexities in interpretation. Clin. Chem. 1995, 41:1814-1818.
135. Lotti M., Caroldi S., Capodicasa E., Moretto A. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol. Appl. Pharmacol. 1991, 108:234-241.
136. Lotti M., Moretto A., Zoppellari R., Dainese R., Rizzuto N., Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch. Toxicol. 1986, 59(3):176-179.
137. Lowe E.R., Poet T.S., Rick D.L., Marty M.S., Mattsson J.L., Timchalk C., Bartels M.J. The effect of plasma lipids on the pharmacokinetics of chlorpyrifos and the impact on interpretation of blood biomonitoring data. Toxicol. Sci. 2009, 108,2:258-272.
138. Ma T., Chambers J.E. Kinetic parameters of desulfuration and dearylation of parathion and chlorpyrifos by rat liver microsomes. Fd. Chem. Toxicol. 1994, 32:763-767.
139. Mage D.T. Dermal absorption of chlorpyrifos. Ann. Occup. Hyg. 2006, 50(6):638-640.
140. Maroni M., Colosio C., Ferioli A., Fait A. Organophosphorous pesticides. Toxicology 2000, 143:9-37.
141. Marsh S., Xiao M., Yu J., Ahluwalia R., Minton M., Freimuth R.R., Kwok P.Y., McLeod H.L. Pharmacogenomic assessment of carboxylesterases 1 and 2. Genomics 2004, 84:661-668.
142. Mattsson J.L., Maurissen J.P., Nolan R.J., Brzak K.A. Lack of differential sensitivity to cholinesterase inhibition in fetuses and neonates compared to dams treated perinatally with chlorpyrifos. Toxicol. Sci. 2000, 53:438-446.
143. Mattsson J.L., Wilmer J.W., Shankar M.R., Berdasco N.M., Crissman J.W., Maurissen J.P., Bond D.M. Single-dose and 13-week repeated-dose neurotoxicity screening studies of chlorpyrifos insecticide. Food Chem. Toxicol. 1996, 34(4):393-405.
144. Maurissen J.P., Hoberman A.M., Garman R.H., Hanley T.R. Lack of selective developmental neurotoxicity in rat pups from dams treated by gavage with chlorpyrifos. Toxicol. Sci. 2000, 57(2):250-263.
145. Maurissen J.P., Shankar M.R., Mattsson J.L. Chlorpyrifos: lack of cognitive effects in adult Long-Evans rats. Neurotoxicol. Teratol. 2000, 22(2):237-246.
146. McBain J.B., Yamamoto I., Casida J.E. Mechanism of activation and deactivation of Dyfonate (O-ethyl S- Phenyl ethylphosphonodithionate) by rat liver microsomes. Life Sci. 1971, 10:947-954.
147. McCollister S.B., Kociba R.J., Humiston C.G., McCollister D.D., Gehring P.J. Studies of the acute and long-term oral toxicity of chlorpyrifos (O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothionate. Food Cosmet. Toxicol. 1974, 12:45-61.
148. Meeker J.D., Ryan L., Barr D.B., Hauser R. Exposure to nonpersistent insecticides and male reproductive hormones. Epidemiology 2006, 17(1):61-68.
149. Meuling W.J.A., Ravensberg L.C., Roza L., van Hemmen J.J. Dermal absorption of chlorpyrifos in human volunteers. Arch. Occup. Environ. Health 2005, 78:44-50.
150. Morgan M.K., Sheldon L.S., Croghan C.W., Jones P.A., Robertson G.L., Chuang J.C., Wilson N.K., Lyu C.W. Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments. J. Expos. Anal. Environ. Epidemiol. 2005, 15:297-309.
151. Mortensen S.R., Chanda S.M., Hooper M.J., Padilla S. Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. J. Biochem. Toxicol. 1996, 11:279-287.
152. Mortensen S.R., Hooper M.J., Padilla S. Rat brain acetylcholinesterase activity: developmental profile and maturational sensitivity to carbamate and organophosphorus inhibitors. Toxicology 1998, 125:13-19.
153. Moser V.C., Casey M., Hamm A., Carter W.H., Simmons J.E., Gennings C. Neurotoxicological and statistical analyses of a mixture of five organophosphorus pesticides using a ray design. Toxicol. Sci. 2005, 86(1):101-115.
154. Moser V.C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 1998, 149:107-119.
155. Moser V.C., Simmons J.E., Gennings C. Neurotoxicological interaction of five-pesticide mixture in preweanling rats. Toxicol. Sci. 2006, 92(1):235-245.
156. Mutch E., Williams F.M. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology 2006, 224:22-32.
157. Nolan R.J., Rick D.L., Freshour N.L., Saunders J.H. Chlorpyrifos: pharmacokinetics in human volunteers. Toxicol. Appl. Pharmacol. 1984, 73(1):8-15.
158. Nordstrand A.C., Padilla S., Moser V.C. The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition and muscarinic receptor density in rats. Pharmacol. Biochem. Behav. 1997, 58:15-23.
159. NRA (2005). The NRA review of chlorpyrifos. APVMA. Canberra.
160. Obach R.S., Zhang Q.-Y., Dunbar D., Kaminski L.S. Metabolic characterization of the major human small intestinal cytochrome P450s. Drug Metab. Disp. 2001, 29(3):347-352.
161. Ostrea E.,M., Bielawski D.M., Posecion N.C., Corrion M., Villanueva-Uy E., Bernardo R.C., Jin Y., Janisse J.J., Ager J.W. Combined analysis of prenatal (maternal hair and blood) and neonatal (infant hair, cord blood and meconium) matrices to detect fetal exposure to environmental pesticides. Environ. Res. 2009, 109(1):116-122.
162. Paine M.F., Hart H.L., Ludington S.S., Haining R.L., Rettie A.E., Zeldin D.C. The human intestinal cytochrome P450 "Pie". Drug Metab. Disp. 2006, 34(5):880-886.
163. Patnaik K.K., Tripathy N.K. Farm-grade chlorpyrifos (Durmet) is genotoxic in somatic and germ-line cells of Drosophila. Mutat. Res. 1992, 279:15-20.
164. PMRA (2003). Proposed Acceptability for Continuing Registration: Phase 2 of the Re-evaluation of Chlorpyrifos. 2003. Ontario, Health Canada.
165. Poet T.S., Wu K., Kousba A.A., Timchalk C. In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon. Toxicol. Sci. 2003, 72(2):193-200.
166. Pond A.L., Chambers H.W., Chambers J.E. Organophosphate detoxication potential of various rat tissues via A-esterase and aliesterase activities. Toxicol. Lett. 1995, 78:245-252.
167. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity?. J. Toxicol. Environ. Health B Crit. Rev. 1999, 2(2):161-181.
168. Pope C.N., Chakraborti T.K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology 1992, 73:35-43.
169. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol. Biochem. Behav. 1992, 42:251-256.
170. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology 1991, 68:51-61.
171. Pope C.N., Karanth S., Liu J., Yan B. Comparative carboxylesterase activities in infant and adult liver and their in vitro sensitivity to chlorpyrifos oxon. Regul. Toxicol. Pharmacol. 2005, 42:64-69.
172. Rahman M.F., Mahboob M., Danadevi K., Saleha Banu B., Grover P. Assessment of genotoxic effects of chloropyriphos and acephate by the comet assay in mice leucocytes. Mutat. Res. 2002, 516:139-147.
173. Rauh V.A., Garfinkel R., Perera F.P., Andrews H.F., Hoepner L., Barr D.B., Whitehead R., Tang D., Whyatt R.W. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 2006, 118(6):1845-1859.
174. Rauh V.A., Perera F.P., Tang D., Barr D., Camann D.E., Kinney P.L., Andrews H.F., Wyatt R.M. Relationship between prenatal environmental exposures, birth outcomes and cognitive development in an urban minority cohort. Epidemiology 2004, 15(4):S87.
175. Ray D.E. Chronic effects of low level exposure to anticholinesterases-a mechanistic review. Toxicol. Lett. 1998, 102-103:527-533.
176. Ray D.E. Pesticide neurotoxicity in Europe: Real risks and perceived risks. Neurotoxicology 2000, 21:219-221.
177. Ricceri L., Venerosi A., Capone F., Cometa M.F., Lorenzini P., Fortuna S., Calamandrei G. Developmental neurotoxicity of organophosphorous pesticides: Fetal and neonatal exposure to Chlorpyrifos alters sex-specific behaviors at adulthood in mice. Toxicol. Sci. 2006, 93:105-113.
178. Richards P., Johnson M.K., Ray D.E., Walker C. Novel protein targets for organophosphorous compounds. Chem. Biol. Interact. 1999, 119-120:503-511.
179. Richardson J.R., Chambers H.W., Chambers J.E. Analysis of the additivity of in vitro inhibition of cholinesterase by mixtures of chlorpyrifos-oxon and azinphos-methyl-oxon. Toxicol. Appl. Pharmacol. 2001, 172:128-139.
180. Richardson J.R., Chambers J.E. Effects of gestational exposure to chlorpyrifos on postnatal central and peripheral cholinergic neurochemistry. J. Toxicol. Environ. Health A 2003, 66(3):275-289.
181. Richardson J.R., Chambers J.E. Effects of repeated oral postnatal exposure to chlorpyrifos on cholinergic neurochemistry in developing rats. Toxicol. Sci. 2005, 84(2):352-359.
182. Richardson R.J. Assessment of the Neurotoxic Potential of chlorpyrifos relative to other organophosphorous compounds: A critical review of the literature. J. Toxicol. Envirom. Health 1995, 44:135-165.
183. Rigas M.L., Okino M.S., Quackenboss J.J. Use of pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurment. Toxicol. Sci. 2001, 61(2):374-381.
184. Rojas-Garcia A.E., Solis-Heredia M.J., Pina-Guzman B., Vega L., Lopez-Carrillo L., Quintanilla-Vega B. Genetic polymorphisms and activity of PON1 in a Mexican population. Toxicol. Appl. Pharmacol. 2005, 205:282-289.
185. Roldan-Tapia L., Nieto-Escamez F.A., del Aguila E.M., Laynez F., Parron T., Sanchez-Santed F. Neuropsychological sequelae from acute poisoning and long-term exposure to carbamate and organophosphate pesticides. Neurotoxicol. Teratol. 2006, 28(6):694-703.
186. Rose R.L., Hodgson E. Pesticide metabolism and potential for metabolic interactions. J. Biochem. Mol. Toxicol. 2005, 19(4):276-277.
187. Ross M.K., Crow J.A. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. J. Biochem. Mol. Toxicol. 2007, 21:187-196.
188. Roy T.S., Andrews J.E., Seidler F.J., Slotkin T.A. Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology 1998, 58:62-68.
189. Rubin Y., Nyska A., Warner T. Pyrnex, teratogenicity study in the rabbit 1987, Life Science Res. Ltd., Ness Ziona, Israel.
190. Sams C., Cocker J., Lennard M.S. Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP). Xenobiotica 2004, 34(10):861-873.
191. Samsam T.E., Hunter D.L., Bushnell P.J. Effects of chronic dietary and repeated acute exposure to chlorpyrifos on learning and sustained attention in rats. Toxicol. Sci. 2005, 87(2):460-468.
192. Sanchez-Amate M.C., Flores P., Sanchez-Santed F. Effects of chlorpyrifos in the plus-maze model of anxiety. Behav. Pharmacol. 2001, 12(4):285-292.
193. Sanchez-Santed F., Canadas F., Flores P., Lopez-Grancha M., Cardona D. Long-term functional neuro-toxicity of paraoxon and chlorpyrifos:behavioural and pharmacological evidence. Neurotoxicol. Teratol. 2004, 26:305-317.
194. Sanghi R., Pillai M.K., Jayalekshmi T.R., Nair A. Organochlorine and organophosphorus pesticide residues in breast milk from Bhopal, Madhya Pradesh, India. Hum. Exp. Toxicol. 2003, 22:73-77.
195. Satoh T., Hosokawa M. The Mammalian Carboxylesterase. Annu. Rev. Pharmacol. Toxicol. 1998, 38:257-288.
196. Satoh T., Taylor P., Bosron W.F., Sanghani S.P., Hosokawa M., La Du B.N. Current progress on esterases: From molecular structure to function. Drug Metab. Disp. 2002, 30:488-493.
197. Savage E.P., Keefe T.J., Mounce L.M., Heaton R.K., Lewis J.A., Burcar P.J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch. Environ. Health 1988, 43(1):38-45.
198. Schuetz J.D., Kauma S., Guzelian P.S. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J. Clin. Invest. 1993, 92:1018-1024.
199. Schurdut B.A., Barraj L., Francis M. Aggregate exposures under the food quality protection act: an approach using chlorpyrifos. Regul. Toxicol. Pharmacol. 1998, 28:165-177.
200. Sherman J.D. Organophosphate pesticides-neurological and respiratory toxicity. Toxicol. Industr. Health 1995, 11:1.
201. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 1999, 107(Suppl 1):71-80.
202. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 2004, 198(2):132-151.
203. Slotkin T.A., Levin E.D., Seidler F.J. Comparative developmental neurotoxicity of organophosphate insecticides: effects on brain development are separable from systemic toxicity. Environ. HealthPerspect. 2006, 114:746-751.
204. Slotkin T.A., Tate C.A., Cousins M.M., Seidler F.J. Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res. Dev. Brain Res. 2002, 133:163-173.
205. Smith G.N., Watson B.S., Fischer F.S. Investigations on dursban insecticide: metabolism of [36Cl]O,O-diethyl)-3,5,6-trichloro-2-pyridyl phosphorothioate in rats. J. Agric. Food Chem. 1967, 15:132-138.
206. Sobti R.C., Krishan A., Pfaffenberger C.D. Cytokinetic and cytogenetic effects of some agricultural chemicals on human lymphoid cells in vitro: organophosphates. Mutat. Res. 1982, 102:89-102.
207. Steenland K., Jenkins B., Ames R.G., O'Malley M., Chrislip D., Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am. J. Public Health 1994, 84(5):731-736.
208. Sultatos L.G. Mammalian toxicology of organophosphorus pesticides. J. Toxicol. Environm. Health 1994, 43:271-289.
209. Sultatos L.G., Chao M., Murphy S.D. The role of hepatic biotransformation in mediating the acute toxicity of the phorothionate insecticide chlorpyrifos. Toxicol. Appl. Pharmacol. 1984, 73:60-68.
210. Sultatos L.G., Costa L.G., Murphy S.D. Determination of organophosphorous insecticides, their oxygen analogs and metabolites by high pressure liquid chromatography. Chromatogaphia 1982, 15(10):669-671.
211. Sultatos L.G., Minor L.D., Murphy S.D. Metabolic activation of phosphorothionate pesticides: Role of the liver. J. Pharmacol. Exp. Therap. 1984, 232(3):624-628.
212. Talcott R.E., Denk H., Mallipudi N.M. Malathion carboxylesterase activity in human liver and its inactivation by isomalathion. Toxicol. Appl. Pharmacol. 1979, 49:373-376.
213. Talcott R.E., Mallipudi N.M., Umetsu N.M., Fukuto T.R. Inactivation of esterases by impurities isolated from technical malathion. Toxicol. Appl. Pharmacol. 1979, 49:107-112.
214. Tang J., Cao Y., Rose R.L., Brimfield A.A., Dai D., Goldstein J.A., Hodgson E. Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Disp. 2001, 29(9):1201-1204.
215. Tang J., Cao Y., Rose R.L., Hodgson E. In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem-Biol. Interact. 2002, 141:229-241.
216. Taylor P. Anticholinesterase agents. The Pharmacological Basis of Therapeutics 1996, 161-176. McGraw-Hill, New York, NY. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A. Goodman (Eds.).
217. Tilson, H. A., Boyes, W. K., Bushnell, P. J., MacPhail, R. C., Padilla, S., Stanton, M. E., and Veronesi, B. (1993). Cholinesterase inhibitors: ongoing and proposed research needs. In "Use of cholinesterase methodologies" (L. Jowa and and R. A. Howd, ed.), Office of Environmental Health Hazard Assessment Cal/EPA.
218. Timchalk C., Busby A., Campbell J.A., Needham L.L., Barr D.B. Comparative pharmacokinetics of the organophosphorus insecticide chlorpyrifos and its major metabolites diethylphosphate, diethylthiophosphate and 3,5,6-trichloro-2-pyridinol in the rat. Toxicology 2007, 237:145-157.
219. Timchalk C., Kousba A., Poet T.S. Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model. Toxicol. Lett. 2002, 135:51-59.
220. Timchalk C., Nolan R.J., Mendrala A.L., Dittenber D.A., Brzak K.A., Mattsson J.L. A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol. Sci. 2002, 66:34-53.
221. Timchalk C., Poet T.S. Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat. Neurotoxicology 2008, 29(3):428-443.
222. Timchalk C., Poet T.S., Kousba A. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos. Toxicology 2006, 220:13-25.
223. U.S. EPA (1989). Registration Standard (Second Round Review) for the Reregistration of Pesticide Products Containing Chlorpyrifos. 5-44. Washington DC, US EPA.
224. U.S. EPA (2000a). Human Health Risk Assessment: Chlorpyrifos. (O.P.P. Health Effects Division, ed.), US EPA, Washington DC.
225. U.S. EPA (2000b). Office of pesticide programs science policy on the use of data on cholinesterase inhibition for risk assessments of organophosphorus and carbamate pesticides. (Office of Pesticide Programs, ed.), US EPA, Washington DC.
226. U.S. EPA (2002). Interim Reregistration Eligibility Decision for Chlorpyrifos. US EPA, Washington, DC. http://www.epa.gov/oppsrrd1/reregistration/status.htm.
227. U.S. EPA (2006). Organophosphorus Cumulative Risk Assessment, US EPA, Washington, DC. http://www.epa.gov/pesticides/cumulative/2006-op/index.htm.
228. U.S. EPA (2008a). September 16-19, 2008: The Agency's evaluation of the toxicity profile of chlorpyrifos. Appendix A: Metabolism. (US EPA, ed.), Washington, DC. http://www.epa.gov/scipoly/sap/meetings/2008/091608_mtg.htm.
229. U.S. EPA (2008b). September 16-19,2008: The Agency's evaluation of the toxicity profile of chlorpyrifos. Appendix C: Effects on the developing brain. (US EPA, ed.), Washington, DC. Available at:. http://www.epa.gov/scipoly/sap/meetings/2008/091608_mtg.htm.
230. U.S. EPA (2008c). September 16-19, 2008: The Agency's evaluation of the toxicity profile of chlorpyrifos. Appendix D: Human epidemiology: effects in children. (US EPA, ed.), Washington, DC. Available at:. http://www.epa.gov/scipoly/sap/meetings/2008/091608_mtg.htm.
231. U.S. Public Health Service (1995). Hazardous Substance Data Bank. 5-9. Washington DC.
232. Usmani K.A., Cho T.M., Rose R.L., Hodgson E. Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals. Drug Metab. Disp. 2006, 34:1606-1614.
233. Usmani K.A., Rose R.L., Goldstein J.A., Taylor W.G., Brimfield A.A., Hodgson E. In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide. Drug Metab. Disp. 2002, 30:289-294.
234. Usmani K.A., Rose R.L., Hodgson E. Inhibition and activation of the human liver and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals. Drug Metab. Disp. 2003, 31:384-391.
235. Valcke, M., and Bouchard, M. (2009). Determination of no-observed effect level (NOEL)-biomarker equivalents to interpret biomonitoring data for organophosphorus pesticides in children. Environ. Health 8:5,. http://www.ehjournal.net/content/8/1/5.
236. van Gemert M., Dourson M., Moretto A., Atson M. Use of human data for the derivation of a reference dose for chlorpyrifos. Regul. Toxicol. Pharmacol. 2001, 33:110-116.
237. Venerosi A., Calamandrei G., Ricceri L. A social recognition test for female mice reveals behavioral effects of developmental chlorpyrifos exposure. Neurotoxicol. Teratol. 2006, 28(4):466-471.
238. Venerosi, A., Ricceri, L., Scattoni, M. L., and Calamandrei, G. (2009). Prenatal chlorpyrifos exposure alters motor behavior and ultrasonic vocalization in CD-1 mouse pups. Environ. Health 8,1/12. http://www.ehjournal.net/content/8/1/12.
239. Waddell B.L., Zahm S.H., Baris D., Weisenburger D.D., Holmes F., Burmeister L.F., Cantor K.P., Blair A. Agricultural use of organophosphate pesticides and the risk of non-Hodgkin's lymphoma among male farmers (United States). Cancer Causes Control 2001, 12(6):509-517.
240. Warner S.D., Gerbig C.G., Strebing R.J., Molello J.A. Results of a Two-Year Toxicity and Oncogenicity Study of Chlorpyrifos Administered to CD-1 Mice in the Diet 1980, Dow Chemical Co., Midland MI.
241. Watanabe A.M. Cholinoreceptor-activating drugs. Basic and Clinical Pharmacology 1989, 70-105. Appleton & Lange, East Norwalk. B.G. Katzung, (Ed.).
242. Water M.D., Simmon V.F., Mitchell A.D., Jorgenson T.A., Valencia R. An overview of short-term tests for the mutagenic and carcinogenic potential of pesticides. J. Environ. Sci. Health B 1980, 15:867-906.
243. WHO (2007). WHO specifications and evaluations for public health pesticides: Chlorpyrifos. http://www.who.int/en/.
244. Whyatt R.M., Barr D.B. Measurement of organophosphate metabolites in postpartum meconium as potential biomarker of prenatal exposure: a validation study. Environ. Health Perspect. 2001, 109(4):417-420.
245. Whyatt R.M., Rauh V., Barr D.B., Camann D.E., Andrews H.F., Garfinkel R., Hoepner L.A., Diaz D., Dietrich J., Reyes A., Tang D., Kinney P.L., Perera F.P. Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ. Health Perspect. 2004, 112(10):1125-1132.
246. Wilson N.K., Chuang J.C., Lyu C., Menton R., Morgan M.K. Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home. J. Expos. Anal. Environ. Epidemiol. 2003, 13:187-202.
247. Woodruff R.C., Phillips J.P., Irwin D. Pesticide-induced complete and partial chromosome loss in screens with repair-defective females of Drosophila melanogaster. Environ Mutagen 1983, 5:835-846.
248. Wu H., Poet T.S., Timchalk C. Inhibition of diazinon metabolism by chlorpyrifos in rat liver microsomes. Toxicol. Sci. 2004, 78(1-S):425.
249. Yano B.L., Young J.T., Mattsson J.L. Lack of carcinogenicity of chlorpyrifos insecticide in a high-dose, 2-year dietary toxicity study in Fischer 344 rats. Toxicol. Sci. 2000, 53:135-144.
250. Yasmashita M., Tanaka J., Ando Y. Human mortality in organophosphate poisoning. Vet. Human Toxicol. 1997, 39:84-85.
251. Yeary R.A., Eaton J., Gilmore E., North B., Singell J. A multiyear study of blood cholinesterase activity in urban pesticide applicators. J. Toxicol. Environ. Health 1993, 39(1):11-25.
252. Young, J. T., and Grandjean, M. (1988). Chlorpyrifos: 2-year dietary chronic toxicity-oncogenicity study in Fischer 344 rats. Study ID: K- 044793-079, dated December 23, 1988. [Dow; Submission 11462, reference 73. Reviewed by PMRA]. Lake Jackson Research Center, Texas, Dow Chemical Co.
253. Zhang Q.-Y., Dunbar D., Ostrowska A., Zeisloft S., Yang J., Kaminski L.S. Characterization of human small intestinal cytochromes P-450. Drug Metab. Disp. 1999, 27(7):804-809.
254. Zhang X., Driver J.H., Li Y., Ross J.K., Krieger R.I. Dialkylphosphates (DAPs) in fruits and vegetables may confound biomonitoring in organophosphorus insecticide exposure and risk assessment. J. Agric. Food Chem. 2008, 56(22):10638-10645.
255. Zhao Q., Dourson M., Gadagbui B. A review of the reference dose for chlorpyrifos. Regul. Toxicol. Pharmacol. 2006, 44(2):111-124.
256. Zheng Q., Olivier K., Won Y.K., Pope C.N. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweaning and adult rats. Toxicol. Sci. 2000, 55:124-132.